Table 2:
Patient | Age at Diagnosis | Germline Mutation | Stage | Neoadjuvant Chemotherapy | Surgery Outcome | Concurrent Endometriosis |
---|---|---|---|---|---|---|
1 | 69 | negative | IVB | No | OD | No |
2 | 58 | negative | IIA | No | CGR | No |
3 | 34 | negative | IIIC | Yes | SD | Yes |
4 | 67 | - | IC | No | OD | No |
5 | 63 | PMS2 | IIIA1 | No | CGR | Yes |
6 | 53 | negative | IVB | No | OD | Yes |
7 | 50 | negative | IIIC | No | OD | Yes |
8 | 38 | negative | IVB | Yes | CGR | Yes |
9 | 49 | SDHA | IIIA2 | No | CGR | Yes |
10 | 47 | negative | IIIB | No | OD | Yes |
11 | 54 | BRCA1 | IVB | No | SD | No |
12 | 62 | negative | IIIC | Yes | OD | No |
13 | 48 | - | IC | No | - | No |
14 | 58 | - | IIIB | No | - | Yes |
15 | 42 | - | IV | Yes | - | No |
16 | 47 | - | IIIA | No | CGR | Yes |
OD: optimal debulking; CGR: complete gross resection; SD: suboptimal debulking